This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Agis Industries (1983) Ltd.. Active years: 1996-1999.
Location History:
- Beer Sheva, IL (1996)
- Beer-Shava, IL (1999)
Company Filing History:
Years Active: 1996-1999
Title: Rina Uzan: Innovator in Topical Pharmaceutical Compositions
Introduction
Rina Uzan is a notable inventor based in Beersheba, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of topical preparations for treating skin lesions and viral infections. With a total of 2 patents, her work has the potential to impact many individuals suffering from skin conditions.
Latest Patents
Rina Uzan's latest patents include a topical preparation for the prevention and treatment of lesions and sores associated with herpes virus. This invention comprises a salt of an unsaturated C.sub.14-18 fatty acid with 1-2 double bonds as the active ingredient, combined with a pharmaceutically or cosmetically acceptable carrier. Another significant patent is an acyclovir antiviral gel composition, which is designed for treating viral diseases of the skin or mucosa. This composition includes a poorly soluble antiviral nucleoside derivative, dispersed in an aqueous gel carrier containing a gelling agent and a water-soluble carboxylic or dicarboxylic acid salt.
Career Highlights
Rina Uzan is currently associated with Agis Industries (1983) Ltd., where she continues to innovate in the pharmaceutical sector. Her work focuses on developing effective treatments that can improve the quality of life for patients dealing with viral infections and skin lesions.
Collaborations
Rina collaborates with Amnon Sintov, contributing to the advancement of pharmaceutical technologies and innovations.
Conclusion
Rina Uzan's contributions to the field of pharmaceuticals through her innovative patents highlight her dedication to improving healthcare solutions. Her work exemplifies the impact that inventors can have on society through their inventions.